Shares of Acadia Pharmaceuticals ACAD lost 9.9% on Wednesday after the company announced a disappointing update from a late-stage study of its investigational candidate, intranasal carbetocin (ACP-101 ...

It was a busy week for the biotech sector as usual, with lots of regulatory and pipeline updates, before the first-quarter earnings season kicks in. Among these, biotech giant Bristol Myers Squibb BMY ...

It was a low-key week for the biotech sector, with nothing important from the bigwigs. Regular pipeline and other updates continue to be in the news. Among these, Sage Therapeutics, Inc. SAGE is ...

Nurses were more likely to be responsible for medication errors in EDs, according to a study published in the Journal of Emergency Medicine. • Physicians were responsible for 24 percent of errors, ...

A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain people ...

People with HIV on long-term antiretroviral therapy and with CD4 counts above 500 face infection risks similar to the general population, a new cohort study finds.